Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Shareholder Equity 2012–2025
Coherus Biosciences Inc. annual/quarterly shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Coherus Biosciences Inc. shareholder equity for the quarter ending December 31, 2025 were 61.0M, a 146.23% decrease year-over-year.
- Coherus Biosciences Inc. shareholder equity for 2025 were 61.0M, a 146.23% decrease from 2024.
- Coherus Biosciences Inc. shareholder equity for 2024 were -132.0M, a 31.76% decrease from 2023.
- Coherus Biosciences Inc. shareholder equity for 2023 were -193.4M, a 40.76% increase from 2022.
- Coherus Biosciences Inc. shareholder equity for 2022 were -137.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Coherus Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $61 |
| 2024 | $-132 |
| 2023 | $-193 |
| 2022 | $-137 |
| 2021 | $98 |
| 2020 | $281 |
| 2019 | $105 |
| 2018 | $-39 |
| 2017 | $31 |
| 2016 | $21 |
| 2015 | $-6 |
| 2014 | $67 |
| 2013 | $-97 |
| Coherus Biosciences Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $61 |
| 2024-12-31 | $-132 |
| 2023-12-31 | $-193 |
| 2022-12-31 | $-137 |
| 2021-12-31 | $98 |
| 2020-12-31 | $281 |
| 2019-12-31 | $105 |
| 2018-12-31 | $-39 |
| 2017-12-31 | $31 |
| 2016-12-31 | $21 |
| 2015-12-31 | $-6 |
| 2014-12-31 | $67 |
| 2013-12-31 | $-97 |
Coherus Biosciences Inc. Shareholder Equity — FAQ
Coherus Biosciences Inc. (CHRS) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CHRS's shareholder equity history?
The chart and table above show Coherus Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.